Targeting CD146 using folic acid-conjugated nanoparticles and suppression of tumor growth in a mouse glioma model.
CONCLUSIONS: CD146 is a potential therapeutic target, and folic acid-conjugated NPs delivering siRNA may facilitate gene therapy in malignant gliomas.
PMID: 32707539 [PubMed - as supplied by publisher]
Source: Journal of Neurosurgery - Category: Neurosurgery Authors: Fukui N, Yawata T, Nakajo T, Kawanishi Y, Higashi Y, Yamashita T, Aratake T, Honke K, Ueba T Tags: J Neurosurg Source Type: research
More News: Brain | Brain Tumor | Cancer & Oncology | Folic Acid | Gene Therapy | Genetics | Glioma | Nanotechnology | Neurology | Neurosurgery | Polyethylene Glycol | Sodium Chloride | Stem Cell Therapy | Stem Cells | Study | Vitamin B9